Waldencast announces conclusion of SEC investigation Seer to Report Third Quarter Financial Results on November 9, 2021
REDWOOD CITY, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a life…
CRISPR Therapeutics Reports Positive Results from its Phase 1 CARBON Trial of CTX110™ in Relapsed or Refractory CD19+ B-cell malignancies
-58% overall response rate (ORR) and 38% complete response (CR) rate in large B-cell lymphoma…
Prometheus Biosciences to Present at Jefferies Virtual Next Generation IBD Therapeutics Summit
SAN DIEGO, Oct. 12, 2021 (GLOBE NEWSWIRE) — Prometheus Biosciences, Inc. (Nasdaq: RXDX), today announced…
EyePoint Pharmaceuticals Presents Preliminary Safety Data from Phase 1 DAVIO Trial and YUTIQ® CALM Registry Study at American Society of Retina Specialists (ASRS) 39th Annual Meeting
– 3-month safety data from DAVIO trial continues to demonstrate EYP-1901 is well-tolerated in eyes…
About the received documents
Joint Stock Company “Olainfarm”, hereinafter – the Company, has received from Black Duck Invest a.s….
Skye Bioscience Establishes New Cannabinoid Pharmaceutical Innovation Program
Exclusive sponsored research agreement with endocannabinoid research pioneers SAN DIEGO, CA, Oct. 12, 2021 (GLOBE…
Ultimovacs ASA: Share capital increase related to exercise of options
Oslo, 12 October 2021, the Board of Directors of Ultimovacs ASA (the “Company”) has resolved…
Evelyn D’An Joins Cytovia Therapeutics as Chief Financial Officer
Key leadership addition to support operational growth and drive company preparedness towards IPO AVENTURA, Fla.,…
Outlook Therapeutics’ Positive NORSE THREE Safety Data Presented at 2021 American Society of Retina Specialists for ONS-5010 Ophthalmic Bevacizumab
Strong safety data from NORSE THREE registration trial consistent with other trials for ONS-5010 and in…
EUROBIO Scientific : 2021 HALF-YEAR EARNINGS
2021 HALF-YEAR EARNINGS EBITDA up +110% to €42.5mNet cash of €60.4mCOVID accelerating the Group’s longstanding…
AGTC to Present at Upcoming Cell & Gene Meeting on the Mesa
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq: AGTC),…
Rakovina Therapeutics Presents at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Presentation highlights pre-clinical data from Rakovina Therapeutics’ novel kt-3000 series dual PARP-HDAC inhibitors VANCOUVER, British…
Psyence Group Jamaica Chief Medical Officer Dr. Dingle Spence to Headline Two Conferences on Psychedelics
TORONTO, Oct. 12, 2021 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG) (“Psyence” or the…
Araris Biotech AG to Present at 12th Annual World ADC Digital Conference
ZURICH, Switzerland, Oct. 12, 2021 (GLOBE NEWSWIRE) — Araris Biotech AG, a company pioneering a…
Vaxil Announces Progress on Research and Development Activities
Figure 1 In vivo mice survival in experimental CRC liver metastasis model Not for distribution…
GeneThera Inc. Enters into an exclusive real estate agreement with Cushman & Wakefield related to the ZIDAS project
WESTMINSTER, Colo., Oct. 12, 2021 (GLOBE NEWSWIRE) — GeneThera, Inc. (OTCMKT: GTHR) announced today that…
Celsion Corporation Announces Oral Presentation at International Vaccines Congress
Chief Science Officer Dr. Khursheed Anwer to Deliver Virtual Presentation on Celsion’s Ongoing Work with…
AXIM® Biotechnologies Develops Next Generation of its Rapid Neutralizing Antibody Test for COVID-19
SAN DIEGO, Oct. 12, 2021 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,”…
Quotient Limited Announces Appointment of Chief Financial Officer
JERSEY, Channel Islands, Oct. 12, 2021 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ: QTNT), a commercial-stage…
Levitee Labs Signs Letter of Intent to Acquire Calgary Addiction and Compounding Pharmacy
Signed LOI to acquire a compounding pharmacy in Calgary, Alberta, Canada Valuation of approximately 3.5x…